Spatiotemporal regulation of Acute Wound Healing by the NLRP3 Inflammasome: Dual Roles in Macrophage-Fibroblast chemotaxis and phenotype during wound repair. Burns & Trauma. DOI: ...

Vitamin C-rich foods, like oranges and bell peppers, are a no-brainer due to their track record in helping lessen the ...

Here's how immune system differences may affect pain recovery in men and women, shaping inflammation, chronic pain risk, and future treatment approaches.

Heart attacks do not happen suddenly - they are built over years of unhealthy habits. Dr Arora shares 5 foods that silently increase your heart attack risk. | Health ...

Nutritionists warn that sleeping after eating heavy meals can disrupt digestion, leading to heartburn, weight gain, and obesity. Learn the risks.

But raw oysters may not be the first thing people feel like eating when under the weather. Another option is a bowl of cereal, which has 2.8 milligrams per serving and is fairly easy on the stomach.

REVB READ THE FULL REVB RESEARCH REPORT Revelation Biosciences (NASDAQ:REVB) is a clinical-stage life sciences company focused on developing therapies that aim to strengthen and modulate the body’s ...

More women are speaking out about endometriosis, an inflammatory disorder that is often diagnosed only because of debilitating, heavy periods or problems conceiving. Recent medical developments, ...

It’s the body’s normal response to infection or injury — but chronic inflammation can lead to health issues. Here’s where inflammation can go wrong and tips for preventing it.

A shingles shot might do more than prevent a painful rash — it could actually help slow down the aging process. In a large national study of more than 3,800 Americans age 70 and older, those who ...

A gel-like sugar coating on immune cells has been found to play a starring role in psoriasis. Researchers discovered that immune cells shed this outer layer to help them exit the bloodstream and enter ...

Equillium (EQ) remains a 'Hold' as it advances EQ504 for ulcerative colitis, with phase 1 trial initiation targeted for mid-2026. Company's Multi-Cytokine Platform enables selective cytokine targeting ...